Media Highlights
New antibody combination shows ‘surprising’ results in high-risk follicular lymphoma trial
December 11, 2023
Dr. Juan Pablo Alderuccio is quoted extensively and identified as the lead author of a study presented at ASH 2023 on pairing the antibodies loncastuximab and rituximab for treatment of patients with follicular lymphoma.
